Abstract
The calcitonin gene-related peptide (CGRP) gene is specifically expressed and regulated in a subset of cell types. Abnormal regulation of CGRP gene expression and/or sensitivity to CGRP actions may contribute to certain pathologies. In this chapter, we will summarize the current state of knowledge on the CGRP promoter and the use of a genetic strategy to sensitize mice to CGRP actions. The CGRP promoter is regulated by two distinct elements: a proximal cyclic AMP response element and a distal, regulated cell-specific enhancer. Both of these elements are activated by mitogen-activated protein kinase (MAPK) signaling pathways. MAPK can stimulate the CGRP promoter in response to proinflammatory cytokines. In addition, CGRP can directly activate these pathways to boost its own expression and potentially increase CGRP actions in a feedback loop. These pathways may contribute to the elevated CGRP levels in migraine and sepsis. Genetic enhancement of the CGRP receptor subunit, receptor activity-modifying protein-1 (RAMP1), increases CGRP actions in vascular smooth muscle and neurons. Potential implications of CGRP elevation and sensitization in migraine will be discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- 3T3:
-
mouse fibroblast cell
- C6:
-
rat glioma cell line
- cAMP:
-
3′-5′-cyclic adenosine monophosphate
- CGRP:
-
calcitonin gene-related peptide
- CMV:
-
cytomegalovirus promoter
- CLR:
-
calcitonin receptor-like receptor
- CRE:
-
cAMP-response element
- CREB:
-
cAMP-response element-binding protein
- CT:
-
calcitonin
- DRG:
-
dorsal root ganglia
- GFP:
-
green fluorescent protein
- hRAMP-1:
-
human receptor activity modifying protein-1
- IL-1β:
-
interleukin 1 beta
- IL-6:
-
interleukin 6
- JNK:
-
c-Jun N-terminal kinase
- LPS:
-
lipopolysaccharide
- MAPK:
-
mitogen-activated protein kinase
- MEK:
-
mitogen-activated protein kinase kinase
- MTC:
-
medullary thyroid cell
- NGF:
-
nerve growth factor
- NO:
-
nitric oxide
- PKA:
-
protein kinase A
- PKC:
-
protein kinase C
- RAMP-1:
-
receptor activity-modifying protein-1
- RCP:
-
receptor component protein
- RRE:
-
ras-responsive element
- RREB:
-
ras-responsive element-binding protein
- SCLC:
-
small cell lung carcinoma
- TNF-α:
-
tumor necrosis factor alpha
- USF:
-
upstream stimulatory factor
Reference
Abemayor E, Sidell N, Juillard G (1989) Human medullary thyroid carcinoma. Initial characterization and in vitro differentiation of two new cell lines. Arch Otolaryngol Head Neck Surg 115:478–483
Ammori BJ, Becker KL, Kite P et al (2003) Calcitonin precursors: early markers of gut barrier dysfunction in patients with acute pancreatitis. Pancreas 27:239–243
Anderson LE, Seybold VS (2004) Calcitonin gene-related peptide regulates gene transcription in primary afferent neurons. J Neurochem 91:1417–1429
Arvieu L, Mauborgne A, Bourgoin S et al (1996) Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord. Neuroreport 7:1973–1976
Attisano L, Silvestri C, Izzi L et al (2001) The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. Mol Cell Endocrinol 180:3–11
Baetscher M, Schmidt E, Shimizu A et al (1991) SV40 T antigen transforms calcitonin cells of the thyroid but not CGRP-containing neurons in transgenic mice. Oncogene 6:1133–1138
Ball DW, Compton D, Nelkin BD et al (1992) Human calcitonin gene regulation by helix–loop–helix recognition sequences. Nucleic Acids Res 20:117–123
Baylin SB, Hoppener JW, de Bustros A et al (1986) DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res 46:2917–2922
Baylin SB, Fearon ER, Vogelstein B et al (1987) Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood 70:412–417
Beer S, Weighardt H, Emmanuilidis K et al (2002) Systemic neuropeptide levels as predictive indicators for lethal outcome in patients with postoperative sepsis. Crit Care Med 30:1794–1798
Bellamy J, Bowen EJ, Russo AF et al (2006) Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 23:2057–2066
Besnard V, Wert SE, Hull WM et al (2004) Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns 5:193–208
Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321:209–213
Bowen EJ, Schmidt TW, Firm CS et al (2006) Tumor necrosis factor-alpha stimulation of calcitonin gene-related peptide expression and secretion from rat trigeminal ganglion neurons. J Neurochem 96:65–77
Broad PM, Symes AJ, Thakker RV et al (1989) Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res 17:6999–7011
Choi RC, Ting AK, Lau FT et al (2007) Calcitonin gene-related peptide induces the expression of acetylcholinesterase-associated collagen ColQ in muscle: a distinction in driving two different promoters between fast- and slow-twitch muscle fibers. J Neurochem 102:1316–1328
Cote GJ, Abruzzese RV, Lips CJ et al (1990) Transfection of calcitonin gene regulatory elements into a cell culture model of the C cell. J Bone Miner Res 5:165–171
Cottrell GS, Roosterman D, Marvizon JC et al (2005) Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 490:239–255
Cruise BA, Xu P, Hall AK (2004) Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev Biol 271:1–10
de Bustros A, Baylin SB, Berger CL et al (1985) Phorbol esters increase calcitonin gene transcription and decrease c-myc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem 260:98–104
de Bustros A, Nelkin BD, Silverman A et al (1988) The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia. Proc Natl Acad Sci U S A 85:5693–5697
de Bustros A, Lee RY, Compton D et al (1990) Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma. Mol Cell Biol 10:1773–1778
de Bustros A, Ball DW, Peters R et al (1992) Regulation of human calcitonin gene transcription by cyclic AMP. Biochem Biophys Res Commun 189:1157–1164
de Bustros A, Baylin SB, Levine MA et al (1986) Cyclic AMP and phorbol esters separately induce growth inhibition, calcitonin secretion, and calcitonin gene transcription in cultured human medullary thyroid carcinoma. J Biol Chem 261:8036–8041
Diener HC, Katsarava Z (2001) Medication overuse headache. Curr Med Res Opin 17(Suppl 1):s17–s21
Domenech VS, Nylen ES, White JC et al (2001) Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Investig Med 49:514–521
Durham PL, Russo AF (1998) Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol Endocrinol 12:1002–1009
Durham PL, Russo AF (1999) Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci 19:3423–3429
Durham P, Russo A (2002) New insights into the molecular actions of serotonergic antimigraine drugs. Pharmacol Ther 94:77–92
Durham PL, Russo AF (2003) Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 23:807–815
Durham PL, Sharma RV, Russo AF (1997) Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation. J Neurosci 17:9545–9553
Durham PL, Dong PX, Belasco KT et al (2004) Neuronal expression and regulation of CGRP promoter activity following viral gene transfer into cultured trigeminal ganglia neurons. Brain Res 997:103–110
Eltorp CT, Jansen-Olesen I, Hansen AJ (2000) Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide. Cephalalgia 20:838–844
Evans BN, Rosenblatt MI, Mnayer LO et al (2000) CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. J Biol Chem 275:31438–31443
Freeland K, Liu YZ, Latchman DS (2000) Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor. Biochem J 345(Pt 2):233–238
Galibert MD, Carreira S, Goding CR (2001) The Usf-1 transcription factor is a novel target for the stress-responsive p38 kinase and mediates UV-induced Tyrosinase expression. Embo J 20:5022–5031
Gallai V, Sarchielli P, Floridi A et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:384–390
Gama-Sosa MA, Slagel VA, Trewyn RW et al (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11:6883–6894
Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48–56
Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183–187
Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine – current understanding and treatment. N Engl J Med 346:257–270
Ho TW, Mannix LK, Fan X et al (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304–1312
Hou L, Li W, Wang X (2003) Mechanism of interleukin-1 beta-induced calcitonin gene-related peptide production from dorsal root ganglion neurons of neonatal rats. J Neurosci Res 73:188–197
Jonk LJ, Itoh S, Heldin CH et al (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273: 21145–21152
Juhasz G, Zsombok T, Modos EA et al (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461–470
Juhasz G, Zsombok T, Jakab B et al (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179–183
Lanigan TM, Russo AF (1997) Binding of upstream stimulatory factor and a cell-specific activator to the calcitonin/calcitonin gene-related peptide enhancer. J Biol Chem 272:18316–18324
Lanigan TM, Tverberg LA, Russo AF (1993) Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer. Mol Cell Biol 13:6079–6088
Lassen LH, Haderslev PA, Jacobsen VB et al (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54–61
Lennerz JK, Ruhle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP recepto. J Comp Neurol 507:1277–1299
Lindsay RM, Harmar AJ (1989) Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337:362–364
Linscheid P, Seboek D, Nylen ES et al (2003) In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 144:5578–5584
Linscheid P, Seboek D, Zulewski H et al (2005) Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 146:2699–2708
Marquez de Prado BRA (2006) CGRP receptor antagonists: a new frontier of anti-migraine medications. Drug Discov Today: Ther Strat 3:593–597
Marquez de Prado BRA, Hammond DL, Russo AF (2009) Genetic enhancement of calcitonin gene-related peptide-induced central sensitization to mechanical stimuli in mice. J Pain In Press
Marvizon JC, Perez OA, Song B et al (2007) Calcitonin receptor-like receptor and receptor activity modifying protein 1 in the rat dorsal horn: localization in glutamatergic presynaptic terminals containing opioids and adrenergic alpha2C receptors. Neuroscience 148: 250–265
McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339
Monla YT, Peleg S, Gagel RF et al (1995) Cell type-specific regulation of transcription by cyclic adenosine 3′, 5′-monophosphate-responsive elements within the calcitonin promoter. Mol Endocrinol 9:784–793
Moriguchi T, Gotoh Y, Nishida E (1995) Activation of two isoforms of mitogen-activated protein kinase kinase in response to epidermal growth factor and nerve growth factor. Eur J Biochem 234:32–38
Muller B, White JC, Nylen ES et al (2001) Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 86:396–404
Naveh-Many T, Silver J (1988) Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. J Clin Invest 81:270–273
Olesen J, Diener HC, Husstedt IW et al (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104–1110
Park KY, Russo AF (2008) Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons. J Biol Chem 283:5441–5451
Peleg S, Abruzzese RV, Cote GJ et al (1990) Transcription of the human calcitonin gene is mediated by a C cell-specific enhancer containing E-box-like elements. Mol Endocrinol 4:1750–1757
Peleg S, Abruzzese RV, Cooper CW et al (1993) Down-regulation of calcitonin gene transcription by vitamin D requires two widely separated enhancer sequences. Mol Endocrinol 7:999–1008
Petersen KA, Lassen LH, Birk S et al (2005) BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202–213
Poyner DR, Sexton PM, Marshall I et al (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233–246
Recober A, Russo AF (2007) Advent of a new generation of anti-migraine medications. In: Sibley D (ed) Handbook of contemporary neuropharmacology. Wiley, Hoboken
Recober A, Russo AF (2007) Olcegepant, a non-peptide CGRP1 antagonist for migraine treatment. IDrugs 10:566–574
Recober A, Kuburas A, Zhang Z et al (2009) Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine. J Neurosci 29:8798–8804
Recober AKA, Zhang A, Russo AF (2007) Developing a potential migraine mouse model. Soc Neurosci Abstracts San Diego 71:76
Rosenfeld MG, Mermod JJ, Amara SG et al (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129–135
Russo AF (2007) Ramping it up: RAMP1 and the implications for migraine. Pharmacogenomics 8:687–690
Russo AF, Dickerson IM (2006) CGRP: A multifunctional neuropeptide. In: Lajtha A (ed) Handbook of neurochemistry and molecular neurology: neuroactive proteins and peptides, 3rd edn. Spriger, New York
Russo AF and Gagel R (2005) Vitamin D control of the calcitonin gene in thyroid C cells. In: Feldman (ed) Vitamin D, 2nd edn. Elsevier Academic, San Diego
Russo AF, Lanigan TM, Sullivan BE (1992) Neuronal properties of a thyroid C-cell line: partial repression by dexamethasone and retinoic acid. Mol Endocrinol 6:207–218
Russo AF, van Otterloo E, Kaiser E, Kuburas A, Zhang Z (2007) Genetic enhancement of CGRP actions: a possible migraine model? Cephalagia 27:624
Seybold VS, McCarson KE, Mermelstein PG et al (2003) Calcitonin gene-related peptide regulates expression of neurokinin1 receptors by rat spinal neurons. J Neurosci 23:1816–1824
Sirito M, Lin Q, Maity T et al (1994) Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res 22:427–433
Thiagalingam A, De Bustros A, Borges M et al (1996) RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 16:5335–5345
Tvedskov JF, Lipka K, Ashina M et al (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561–568
Tverberg LA, Russo AF (1992) Cell-specific glucocorticoid repression of calcitonin/calcitonin gene-related peptide transcription. Localization to an 18-base pair basal enhancer element. J Biol Chem 267:17567–17573
Tverberg LA, Russo AF (1993) Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helix-loop-helix and octamer-binding transcription factors. J Biol Chem 268:15965–15973
Viney TJ, Schmidt TW, Gierasch W et al (2004) Regulation of the cell-specific calcitonin/calcitonin gene-related peptide enhancer by USF and the Foxa2 forkhead protein. J Biol Chem 279:49948–49955
Watson A, Latchman D (1995) The cyclic AMP response element in the calcitonin/calcitonin gene-related peptide gene promoter is necessary but not sufficient for its activation by nerve growth factor. J Biol Chem 270:9655–9660
Weihe E, Nohr D, Schafer MK et al (1995) Calcitonin gene related peptide gene expression in collagen-induced arthritis. Can J Physiol Pharmacol 73:1015–1019
Xu P, Hall AK (2007) Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience 150:665–674
Xu P, Van Slambrouck C, Berti-Mattera L et al (2005) Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J Neurosci 25:9227–9235
Zeytin FN, Rusk S, Leff SE (1987) Calcium, dexamethasone, and the antiglucocorticoid RU-486 differentially regulate neuropeptide synthesis in a rat C cell line. Endocrinology 121: 361–370
Zhang Z, Dickerson IM, Russo AF (2006) Calcitonin gene-related peptide receptor activation by receptor activity-modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology 147:1932–1940
Zhang ZCS, Faraci F, Russo AF (2007) Ramping up CGRP functions in RAMP1 transgenic mice Soc Neurosci Abstracts San Diego 523:519
Zhang Z, Winborn CS, Marquez de Prado B et al (2007b) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693–2703
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V
About this chapter
Cite this chapter
Park, KY., Russo, A.F. (2010). Genetic Regulation of CGRP and Its Actions. In: Hay, D., Dickerson, I. (eds) The calcitonin gene-related peptide family. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2909-6_7
Download citation
DOI: https://doi.org/10.1007/978-90-481-2909-6_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2908-9
Online ISBN: 978-90-481-2909-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)